Editorial: prevalence, progression rates and mortality predictors of non-alcoholic fatty liver disease reflected by German statutory health insurance data

Aliment Pharmacol Ther. 2020 Oct;52(8):1412-1413. doi: 10.1111/apt.16077.

Authors

Tobias Puengel¹, Frank Tacke¹

Affiliation

¹ Department of Hepatology & Gastroenterology, Charité University Medicine Berlin, Berlin, Germany.

PMID: 33105983
DOI: 10.1111/apt.16077

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Disease Progression
Humans
Insurance, Health
National Health Programs
Non-alcoholic Fatty Liver Disease* / diagnosis
Non-alcoholic Fatty Liver Disease* / epidemiology
Prevalence
Risk Factors